Karen Cheng
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria 4
- Gastroenterology top 5%
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 2
- Pharmacology top 10%
- Antibiotics Pharmacokinetics and Efficacy 3
-
- Pneumonia and Respiratory Infections 3
- Urinary Tract Infections Management 2
-
- Advanced Breast Cancer Therapies 2
-
- Diabetes Treatment and Management 2
-
- Pancreatic function and diabetes 2
Karen Cheng
11 papers receiving 625 citations
Hit Papers
Peers
Comparison fields: 5 of 62
- Molecular Medicine 187
- Applied Microbiology and Biotechnology 72
- Gastroenterology 85
- Oncology 267
- Pharmacology 149
Countries citing papers authored by Karen Cheng
This map shows the geographic impact of Karen Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Cheng more than expected).
Fields of papers citing papers by Karen Cheng
This network shows the impact of papers produced by Karen Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Cheng. The network helps show where Karen Cheng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Karen Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 1 | |
| 2 | 2021 | 20 | |
| 3 | 2021 | 9 | |
| 4 | 2020 | 18 | |
| 5 | 2019 | 49 | |
| 6 | 2019 | 56 | |
| 7 | Pertuzumab plus trastuzumab and chemotherapy for HER2-positive metastatic gastric or gastro-oesophageal junction cancer (JACOB): final analysis of a double-blind, randomised, placebo-controlled phase 3 studybreakdown → | 2018 | 336 |
| 8 | 2018 | 13 | |
| 9 | 2014 | 51 | |
| 10 | 2014 | 1 | |
| 11 | 2006 | 80 |
About Karen Cheng
Karen Cheng is a scholar working on Molecular Medicine, Critical Care and Intensive Care Medicine and Pharmacology, having authored 11 papers that have together received 634 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (4 papers), Pneumonia and Respiratory Infections (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Urinary Tract Infections Management (2 papers), Advanced Breast Cancer Therapies (2 papers), Diabetes Treatment and Management (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Pancreatic function and diabetes (2 papers). The work is most often cited by research in Molecular Medicine (187 citations), Applied Microbiology and Biotechnology (72 citations) and Gastroenterology (85 citations). Karen Cheng has collaborated with scholars based in United Kingdom, United States and Spain. Frequent co-authors include Manish A. Shah, Haiyan Wu, Paulo M. Hoff, Atsushi Ohtsu, Josep Tabernero, Jennifer Eng‐Wong, Yoon‐Koo Kang, Chunyan Song, Lin Shen and Katherine Kim. Their work appears in journals such as Cancer Research, The Lancet Oncology and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.